In the realm of GBM investigation, it is preferred to employ GEM models that encompass the upregulation of platelet-derived growth factor (PDGF) or the expression of the mutated variant of the epidermal growth factor receptor (EGFRvIII), thereby emulating genetic occurrences linked to the progression of glioblastoma [32]. Here, EGFR is linked to glioblastoma.